Polypeptide Therapeutic Solutions

Curapath (formerly Polypeptide Therapeutic Solutions) is a globally focused contract development and manufacturing organization (CDMO) specializing in the design, development, and GMP manufacturing of advanced polyamino-acid (PAA) and lipid-based drug delivery systems. The company supports all stages from preclinical to commercial manufacturing, with an emphasis on novel functional excipients, nanoparticle formulations, and non-viral delivery technologies for vaccines, gene therapies, cell therapies, biologics, and small molecules. Curapath’s technology enables precision targeting and improved safety profiles for advanced therapies, and the company has announced expansions to support late-stage clinical and commercial-scale production.